How Long Do Tingling Arms and Legs Last After COVID Vaccine?

For most people, tingling in the arms or legs after a COVID vaccine resolves within about five days. A large Canadian pharmacovigilance study found the median duration of new-onset numbness or tingling was five days, with a typical range of two to fifteen days.¹ That said, the range stretches wider than most people expect, and the duration depends a lot on what is actually causing the sensation. A brief tingle near the injection site and a persistent burning in both feet are very different problems with very different timelines.

What the Population Data Actually Shows

The best numbers we have on timing come from a study that tracked reports of new numbness or tingling following COVID-19 vaccination across Quebec. Symptoms started quickly: the median time from shot to first symptoms was about 24 hours, though some people noticed tingling within a few hours and others not for several days. About four in ten people described their symptoms as mild, and close to half called them moderate.¹

The median five-day duration is reassuring, but the averages can hide the tails of the distribution. Roughly one in eight people in that study reported symptoms lasting between one and five months. About one in a hundred still had symptoms after six months.¹ So while “a few days” is the honest answer for the majority, it is not the universal experience, and people whose symptoms hang around for weeks are not imagining things.

Upper limbs were the most commonly affected area (reported by about 62% of cases), followed by the lower limbs (47%) and the face (42%). Many people had tingling in more than one region at once.¹ Tingling limited to the arm that received the shot tends to resolve fastest, while symptoms that appear on both sides of the body or in the legs sometimes signal a different mechanism at work.

Why Vaccination Can Cause Tingling in the First Place

There are several distinct reasons a vaccine might trigger tingling, and they do not all resolve on the same schedule.

The simplest explanation is mechanical. A needle inserted into the deltoid muscle can occasionally nick or compress a small nerve, cause local swelling, or create a tiny hematoma that presses on nearby nerve fibers. This kind of injury has been documented not just with COVID vaccines but with influenza shots and other intramuscular injections.² Symptoms typically stay close to the injection site, like tingling running down the vaccinated arm, and tend to improve within days to a few weeks as the swelling goes down.

The second and more consequential mechanism is immune-mediated. COVID vaccines are designed to provoke a strong immune response. In rare cases, that immune activation produces antibodies that do not just target the spike protein but accidentally cross-react with components of the peripheral nervous system. This process, sometimes called molecular mimicry, can damage the insulation around nerve fibers or the nerve fibers themselves.³ When the immune system starts attacking peripheral nerves, the tingling tends to be more widespread, more persistent, and sometimes accompanied by weakness or pain. This is the pathway behind more serious post-vaccination nerve conditions.

Short-Lived Tingling vs. Something That Needs Attention

The challenge for anyone experiencing post-vaccine tingling is figuring out whether it falls into the “annoying but temporary” category or the “see a doctor soon” category. There is no perfect bright line, but a few patterns are worth knowing.

Tingling that stays in the vaccinated arm and eases over the first week is almost always benign. It behaves like any other mild injection-site reaction. You might also notice it briefly when moving your shoulder or sleeping on that side, but it does not spread.

Tingling that shows up in both arms or both legs, or that appears far from the injection site, deserves more attention. Symptoms that get progressively worse over days rather than gradually fading are a red flag. Ascending weakness in the legs, difficulty with balance, or tingling that moves from the fingertips upward toward the torso are patterns that clinicians associate with more serious nerve involvement. If you develop trouble breathing, swallowing, or significant limb weakness alongside the tingling, that warrants urgent evaluation.

Recognized Neurological Conditions Linked to COVID Vaccines

Several specific nerve conditions have been reported following COVID-19 vaccination. They are rare, but understanding them helps explain why some people’s tingling lasts far longer than a week.

Guillain-Barré Syndrome

Guillain-Barré syndrome, or GBS, is the most widely discussed post-vaccination nerve complication. It typically begins with tingling and numbness in the feet or hands that progresses over days to weakness, sometimes severe, in the legs and arms. One reported case involved a 62-year-old woman who developed tingling and progressive weakness in both legs over three days, beginning 11 days after receiving her first AstraZeneca dose. Lumbar puncture and nerve conduction studies confirmed GBS.⁴ GBS existed as a known rare complication of other vaccines (particularly influenza vaccines) long before COVID-19. The timeline for GBS recovery varies considerably. Some people recover in weeks with treatment, while others face months of rehabilitation. GBS was more closely associated with the adenoviral-vector vaccines (like AstraZeneca’s) than with mRNA vaccines, though cases have been reported with all types.

Small Fiber Neuropathy

Small fiber neuropathy, or SFN, involves damage to the tiny nerve endings near the surface of the skin. It causes burning pain, tingling, and numbness, often in the hands and feet. Unlike GBS, it does not cause significant muscle weakness, but the sensory symptoms can be debilitating. A case series identified 16 patients with suspected SFN following COVID-19 vaccination, of whom nine met the full diagnostic criteria.⁵

Confirming SFN requires a skin biopsy to count the tiny nerve fibers in a sample from the lower leg or foot. In one well-documented case, a 39-year-old man developed arm pain and numbness that began about ten days after a Pfizer vaccination and progressively spread to involve all four limbs with burning pain and fasciculations. A skin biopsy performed months later showed clearly reduced nerve fiber density in both the calf and foot.⁶ Another early report described three patients who developed burning pain and tingling within days of their first mRNA vaccine dose, with skin biopsies confirming reduced nerve fiber density in all three, and symptoms persisting over the observation period.⁷

SFN is the condition most likely to explain post-vaccine tingling that persists for months. The timeline for recovery is unpredictable and depends heavily on whether and how aggressively it is treated.

Parsonage-Turner Syndrome

Parsonage-Turner syndrome, also called neuralgic amyotrophy, is a condition that causes sudden severe pain in the shoulder followed by weakness and sensory changes in the arm. It is a known complication of various infections, surgeries, and vaccinations.⁸ Cases have been reported after COVID vaccination as well, including one patient who developed escalating pain and weakness in both shoulders and upper limbs after successive doses, confirmed through nerve conduction studies as brachial plexopathy.⁹ Recovery from Parsonage-Turner syndrome is typically slow, often measured in months, though most people eventually regain most of their function.

Treatment and How It Affects Duration

For mild, self-limiting tingling that lasts a few days, no specific treatment is needed. Over-the-counter pain relievers and time are sufficient. The question becomes more interesting for the subset of people whose symptoms do not fade.

The most encouraging treatment data comes from an observational study of 23 patients who developed neuropathic symptoms within a month of COVID vaccination. All of them had severe tingling in the face or limbs, and over half also had symptoms like dizziness on standing and heat intolerance. Among those treated with a short course of oral corticosteroids, about 58% had complete or near-complete improvement within two weeks. By contrast, only about 9% of patients who did not receive any immune-targeted treatment had recovered at twelve weeks. Three patients who had not improved at five to nine months were then given intravenous immunoglobulin (IVIG) and experienced resolution of symptoms within two weeks.¹⁰

That data is from a small, uncontrolled study, so it does not have the weight of a randomized trial. But the pattern is consistent with what neurologists expect from immune-mediated neuropathies: early immunotherapy tends to shorten the course. In the small fiber neuropathy case involving autoantibodies, the patient also improved with IVIG.⁶ The practical takeaway is that people with persistent post-vaccine tingling that is not resolving on its own, particularly when it involves both sides of the body or is accompanied by pain, should not simply wait it out indefinitely. Getting a neurological evaluation opens the door to treatments that can meaningfully shorten how long the symptoms last.

The Gradual Recovery Pattern

Even in cases where symptoms persist for weeks or months, the trajectory is usually one of gradual improvement rather than a sudden switch from symptomatic to normal. One detailed case report tracked a woman who developed numbness in her mouth and feet two weeks after vaccination. Her oral numbness resolved first, within about ten days. Muscular pain subsided after about a month, and leg tingling gradually softened over two months, with nerve conduction studies showing progressive improvement.¹¹

This stepwise pattern is typical. Different body regions can recover at different rates, and the tingling tends to become intermittent before it fully disappears. People often report that their symptoms are worst in the evening, when fatigued, or after exercise, and gradually the symptom-free windows widen until the tingling is no longer part of daily life. This is worth knowing because the slow, nonlinear trajectory can be psychologically frustrating. A day of worsened tingling after several good days does not mean you are going backward.

Distinguishing Post-Vaccine Tingling from Other Causes

One complication that does not get discussed enough is that post-vaccine tingling often surfaces during a period when people are hyperaware of their body’s signals. Mild tingling that a person might normally ignore can become very noticeable when they are watching for side effects. This does not mean the sensation is imagined, but it does mean that not every tingle after a vaccine was caused by that vaccine.

Carpal tunnel syndrome, diabetic neuropathy, cervical disc problems, and even anxiety can all produce tingling in the arms and legs. If you had an existing condition that causes intermittent tingling, a temporary inflammatory boost from the vaccine could plausibly make it more noticeable for a few days without the vaccine having caused nerve damage. Similarly, hyperventilation from anxiety (including needle anxiety) can produce temporary tingling in the hands and around the mouth that resolves within minutes to hours.

Timing helps sort this out. Tingling that started in the vaccinated arm and spread outward over days is more likely to be vaccine-related. Tingling that was present before the vaccine or that follows the distribution of a known preexisting condition is probably coincidental. And transient tingling in the hands and lips that appeared during or immediately after the injection and resolved within an hour is most consistent with a stress response or hyperventilation. If you are uncertain, a neurologist can usually distinguish between these scenarios with a clinical exam and, if needed, nerve conduction testing.

When Vaccines Are Not the Only Suspect

It is worth noting that COVID-19 infection itself causes neuropathic symptoms at a higher rate than the vaccines do. Many of the same immune-mediated mechanisms that occasionally produce tingling after vaccination, including molecular mimicry and autoantibody production, operate more aggressively during actual SARS-CoV-2 infection. GBS, small fiber neuropathy, and long-lasting numbness and tingling have all been documented as consequences of COVID illness. This context matters because deciding whether to get vaccinated (or boosted) involves comparing risks, not just listing side effects in isolation. For most people, the risk of neurological complications from the disease substantially exceeds the risk from the vaccine.

That said, for the rare individual who did develop prolonged neuropathic symptoms after a first dose, the decision about additional doses is worth discussing with a neurologist. Some clinicians recommend switching vaccine platforms (for example, from an adenoviral vector to mRNA, or vice versa), while others recommend postponing boosters until symptoms have fully resolved.

Post-Vaccine Neuropathy Is Not Unique to COVID Shots

Peripheral nerve symptoms after vaccination are not a phenomenon invented by the COVID era. GBS has been associated with influenza vaccines since the 1976 swine flu campaign. Parsonage-Turner syndrome has been reported after hepatitis, tetanus, and other routine immunizations. Even the newer recombinant shingles vaccine (Shingrix) has been linked to prolonged neurological symptoms in case reports, including one patient with Crohn’s disease who developed numbness and tingling that persisted for over a year.¹²

What made post-vaccine tingling so visible with COVID vaccines was the sheer scale of the vaccination campaign. When billions of doses are administered within a short window, even extremely rare side effects generate large absolute numbers of cases. Pharmacovigilance systems that normally collect a handful of reports per year were suddenly flooded, which is both a sign that monitoring was working as intended and a source of understandable public concern. The underlying biology, though, is not new. The immune system occasionally misfires after any strong immune stimulus, and vaccination is one such stimulus.

What a Medical Workup Looks Like

If your tingling has lasted more than two or three weeks, is spreading, or is accompanied by weakness or significant pain, a neurological evaluation is reasonable. Here is what that typically involves, so you know what to expect.

The first step is a detailed history and clinical exam. The neurologist will map exactly where the tingling is, test your strength and reflexes, and look for patterns that point toward specific diagnoses. Nerve conduction studies and electromyography can evaluate the larger nerve fibers, which is useful for diagnosing conditions like GBS or Parsonage-Turner syndrome. However, these tests are often normal in small fiber neuropathy because the affected fibers are too small to register on standard electrical testing.

If small fiber neuropathy is suspected, a skin punch biopsy is the gold standard. The biopsy is minor (a 3 mm sample from the lower leg, typically) and allows direct counting of the tiny nerve fibers in the skin. Blood work may be ordered to check for autoantibodies, diabetes, vitamin deficiencies, and other conditions that can cause or worsen neuropathy. The goal is both to confirm that the neuropathy is real and to rule out other treatable causes that might be contributing.

For someone whose skin biopsy confirms reduced nerve fiber density and whose timeline points clearly to the vaccine as a trigger, the treatment discussion centers on immune-modulating therapies like corticosteroids or IVIG, along with symptomatic management of pain and tingling. Medications commonly used for neuropathic pain, like gabapentin or pregabalin, can help manage symptoms while the underlying nerve damage heals. Recovery of small nerve fibers is possible because, unlike many other nerve cells, these fibers can regenerate, but the process is slow, often taking months.

1
PubMed. New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada
2
PubMed Central. COVID-19 Vaccines and Axillary Nerve Dysfunction: A Case Report – Section: Discussion
3
Clinical Immunology Communications. Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination? – Section: 3. Pathophysiology of Guillain Barré syndrome
4
BMJ Case Reports. Case of Guillain-Barré syndrome following COVID-19 vaccine
5
PubMed. Small fiber neuropathy following COVID-19 vaccination: A case series
6
PubMed Central. Small Fiber Neuropathy Triggered by COVID-19 Vaccination: Association with FGFR3 Autoantibodies and Improvement during Intravenous Immunoglobulin Treatment – Section: Case Report
7
PubMed Central. Post COVID-19 vaccine small fiber neuropathy
8
PubMed Central. Parsonage-Turner syndrome after SARS-CoV-2 vaccination: A case report – Section: Introduction
9
PubMed Central. Parsonage-Turner Syndrome and Vocal Fold Paresis Following Soberana 2 FINLAY-FR-2 COVID-19 Vaccination: A Case Report
10
PubMed Central. Neuropathic symptoms with SARS-CoV-2 vaccination
11
PubMed Central. Neurological complications following mRNA COVID-19 vaccination: Oral and lower limb paresthesia. A case discussion and literature review – Section: Case Report
12
PubMed Central. Prolonged Neurological and Musculoskeletal Symptoms Following Shingrix Vaccination